• Find people
• Intranet

Translational research group on hematological neoplasms Blanca Espinet

Publications 2024 (17)

• Abril-Pérez C, Mansilla-Polo M^*, Escutia-Muñoz B, Sanmartín O, Garcés JR, Rodríguez-Prieto MA, Ruiz-Salas V, de Eusebio Murillo E, Miñano R, Gonzalez-Sixto B, Artola Igarza JL, Alfaro Rubio A, Redondo P, Delgado-Jiménez Y, Sánchez J, Allende Markixana I, Alonso-Pacheco ML, Garcia-Bracamonte B, De la Cueva-Dobao P, Navarro R, Ciudad C, Carnero-González L, Vázquez-Veiga H, Cano-Martinez N, Serra-Guillén C, Vilarrasa E, Sánchez-Sambucety P, López-Estebaranz JL, Florez-Menéndez A, Martorell-Calatayud A, Gil P, Morales-Gordillo V, Toll A, Ocerin-Guerra I, Mayor Arenal M, Suarez Fernández R, Sainz-Gaspar L, Descalzo MA, García-Doval I, Botella-Estrada R, REGESMOHS (Registro Español de Cirugía de Mohs). Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery). J Eur Acad Dermatol Venereol 2024: (en Premsa).
• Fernández-Miranda I, Pedrosa L, González-Rincón J, Espinet B, de la Cruz F, Climent F, Gomez S, Royuela A, Camacho FI, Martín-Acosta P, Yanguas-Casás N, Domínguez M, Méndez M, Colomo L, Salar A, Horcajo B, Navarro M, García-Cosio M, Piris-Villaespesa M, Llanos M, García JF, Sequero S, Mercadal S, García-Hernández S, Navarro B, Mollejo M, Provencio M, Sánchez Beato M^*. Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma. 2024; 37: (en Premsa).
• Pechuan E, Toll A^*, Bergé D, Legido T, Martinez-Sadurni L, Trabsa A, De Iturbe G, García S, Jiménez B, Fernández A, Pérez V, Mané A. Clozapine use in the first two years after first-episode psychosis in a real-world clinical sample. 2024; 2853(24): (en Premsa).
• Calvo X^*. Acute myeloid leukemia at first relapse: approaching the precipice. Haematologia 2024: (en Premsa).
• Freund Y^*, Cancella M, Lebal S, Rousseau A, Lafon T, Yordanov Y, Macrez R, Coisy F, Le Borgne P, Femy F, Douillet D, Robert N, Eyer X, Bouillon-minois JB, Ogereau C, Bouzid D, Goulet H, Roussel M, Rousseau G, Guénézan J, Occelli C, Chouihed T, Osorio-Quispe G, Renad MC, Gorlicki J, Bloom B, Simon T, Gerlier C. Effect of the 1-h bundle on mortality in patients with suspected sepsis in the emergency department: a stepped wedge cluster randomized clinical trial. Int Care Med 2024; 50(7): 1086-1095.
• Giordano S^*, Alamon-Reig F, Luque-Luna M, Castillo P, Toll A, Carrera C. Perianal Basal Cell Carcinoma: A Diagnostic Challenge. Dermatol Pract Concept 2024; 14(3): e2024195.
• Papaleo NF, Molina-Alvarez A, Onieva R, Fuertes D, Sánchez-González B, Riera X, Lopez-Segura D, Lome-Maldonado C, Ara-Mancebo X, Yelamos J, Salido M, Vazquez I, Calvo X, Colomo L^*. Chromogenic LMO2 mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOS. Cancers 2024; 16(13): 2378.
• Mosquera-Orgueira A^*, Pérez-Encinas M, Díaz-Varela N, Wang YH, Mora E, Diaz-Beya M, Montoro MJ, Pomares-Marín H, Ramos-Ortega F, Tormo M, Jerez A, Nomdedeu J, de Miguel-Sanchez C, Arenillas L, Carcel P, Cedena-Romero MT, Xicoy B, Rivero-Arango E, Del Orbe-Barreto R, Benlloch L, Lin CC, Tien HF, Pérez-Míguez C, Crucitti D, Diez-Campelo M, Valcárcel D^*. Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification. Br J Haematol 2024; 204(4): 1529-1535.
• Conde E, Hernandez S, Rodriguez-Carrillo JL, Martinez R, Alonso M, Curto D, Jimenez B, Caminoa A, Benito A, Garrido P, Clavé S, Arriola E, Esteban-Rodriguez I, de Castro J, Sansano I, Felip E, Rojo F, Dómine M, Abdulkader I, Garcia-Gonzalez J, Teixido C, Reguart N, Compañ D, Insa A, Mancheño N, Palanca S, Juan-Vidal O, Baixeras N, Nadal E, Cebollero M, Calles A, Martin P, Salas C, Provencio M, Aranda I, Massuti B, López-Vilaró L, Majem M, Paz-Ares L, López-Ríos F^*. RET Fusion Testing in Patients With NSCLC: The RETING Study. JTO Clin Res Rep . 2024; 5(4): 100653 (Acceptat).
• Levy B, Kanagal-Shamanna R, Sahajpal NS, Neveling K, Rack K, Dewaele B, Olde-Weghuis D, Stevens-Kroef M, Puiggros A, Mallo M, Clifford B, Mantere T, Hoischen A, Espinet B, Kolhe R, Solé F, Raca G, Smith AC^*. A framework for the clinical implementation of optical genome mapping in hematologic malignancies. Am J Hematol 2024; 99(4): 642-661.
• Rodriguez JJ, Ganan-Gomez I, Ma F, Chien K, Del Rey M, Loghavi S, Montalban-Bravo G, Adema V, Wildeman B, Kanagal-Shamanna R, Bazinet A, Chifotides HT, Thongon N, Calvo X, Hernández-Rivas JM, Diez-Campelo M, García-Manero G, Colla S^*. Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes. Nat Commun 2024; 15(1): 2428.
• Blanco G, Lopez-Aventin D, Pujol RM, Gómez-Llonin A, Puiggros A, Lopez-Sanchez M, Estrach T, García-Muret MP, López-Lerma I, Servitje O, Bellosillo B, Muro M, Espinet B, Rabionet R, Gallardo F^*. High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome. J Clin Lab Anal 2024; 37(23-24): e24982.
• Chatzikonstantinou T, Scarfò L, Karakatsoulis G, Minga E, Chamou D, Iacoboni G, Kotaskova J, Demosthenous C, Smolej L, Mulligan S, Alcoceba M, Al-Shemari S, Aurran-Schleinitz T, Bacchiarri F, Bellido M, Bijou F, Calleja A, Medina A, Khan MA, Cassin R, Chatzileontiadou S, Collado R, Christian A, Davis Z, Dimou M, Donaldson D, Santos GD, Dreta B, Efstathopoulou M, El-Ashwah S, Enrico A, Fresa A, Galimberti S, Galitzia A, García-Serra R, Gimeno E, González-Gascón-Y-Marin I, Gozzetti A, Guarente V, Guieze R, Gogia A, Gupta R, Harrop S, Hatzimichael E, Herishanu Y, Hernández-Rivas JÁ, Inchiappa L, Jaksic O, Janssen S, Kalicinska E, Kamel L, Karakus V, Kater AP, Kho B, Kislova M, Konstantinou E, Koren-Michowitz M, Kotsianidis I, Kreitman RJ, Labrador J, Lad D, Levin MD, Levy I, Longval T, Lopez-Garcia A, Marquet J, Martin-Rodríguez L, Maynadié M, Maslejova S, Mayor-Bastida C, Mihaljevic B, Milosevic I, Miras F, Moia R, Morawska M, Murru R, Nath UK, Navarro-Bailón A, Oliveira AC, Olivieri J, Oscier D, Panovska-Stavridis I, Papaioannou M, Papajik T, Kubova Z, Phumphukhieo P, Pierie C, Puiggros A, Rani L, Reda G, Rigolin GM, Ruchlemer R, de Deus MD, Schipani M, Schiwitza A, Shen Y, Simkovic M, Smirnova S, Abdelrahman Soliman, Spacek M, Tadmor T, Tomic K, Tse E, Vassilakopoulos T, Visentin A, Vitale C, von Tresckow J, Vrachiolias G, Vukovic V, Walewska R, Wasik-Szczepanek E, Xu Z, Yagci M, Yáñez L, Yassin M, Zuchnicka J, Angelopoulou M, Antic D, Biderman B, Catherwood M, Claus R, Coscia M, Cuneo A, Demirkan F, Espinet B, Gaidano G, Kalashnikova OB, Laurenti L, Nikitin E, Pangalis GA, Panagiotidis P, Popov VM, Pospisilova S, Sportoletti P, Stavroyianni N, Tam C, Trentin L, Chatzidimitriou A, Bosch F, Doubek M, Ghia P^*, Stamatopoulos K. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. EClinicalMedicine . 2024; 65: 102307 (Acceptat).
• Carbo-Meix A, Guijarro F, Wang L, Grau M, Royo R, Frigola G, Playa-Albinyana H, Buhler MM, Clot G, Duran M, Lu J, Granada I, Baptista MJ, Navarro JT, Espinet B, Puiggros A, Tapia G, Bandiera L, de Canal G, Bonoldi E, Climent F, Ribera-Cortada I, Fernandez-Caballero M, De la Banda E, do Nascimento J, Pineda A, Vela D, Rozman M, Aymerich M, Syrykh C, Brousset P, Perera M, Yanez L, Ortin JX, Tuset E, Zenz T, Cook JR, Swerdlow SH, Martín-Subero JI, Colomer D, Matutes E, Bea S, Costa D, Nadeu F, Campo E^*. BCL3-rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases. Haematologica 2024; 109(2): 493-508.
• Visentin A, Chatzikonstantinou T, Scarfò L, Kapetanakis A, Demosthenous C, Karakatsoulis G, Minga E, Chamou D, Allsup D, Cabrero AA, Andres M, Antic D, Baile M, Baliakas P, Besikli-Dimou S, Bron D, Chatzileontiadou S, Cordoba R, Correa JG, Cuéllar-García C, de Paoli L, de Paolis MR, Delgado J, Dimou M, Donaldson D, Catherwood M, Doubek M, Efstathopoulou M, Eichhorst B, Elashwah S, Enrico A, Espinet B, Farina L, Ferrari A, Foglietta M, Frederiksen H, Fürstenau M, García-Marco JA, García-Serra R, Collado R, Gentile M, Gimeno E, Glenthøj A, DA Silva, Hakobyan YK, Herishanu Y, Hernández-Rivas JÁ, Herold T, Innocenti I, Itchaki G, Jaksic O, Janssens A, Kalashnikova OB, Kalicinska E, Kater AP, Kersting S, Labrador J, Lad D, Laurenti L, Levin MD, Lista E, Lopez-Garcia A, Malerba L, Marasca R, Marchetti M, Marquet J, Mattsson M, Mauro FR, Morawska M, Motta M, Munir T, Murru R, Niemann CU, Rodrigues RN, Olivieri J, Orsucci L, Papaioannou M, Pavlovsky MA, Piskunova I, Popov VM, Quaglia FM, Quaresmini G, Qvist K, Rigolin GM, Ruchlemer R, Simkovic M, Spacek M, Sportoletti P, Stanca O, Tadmor T, Capasso A, del Poeta G, Gutwein O, Karlsson LK, Milosevic I, Mirás F, Reda G, Saghumyan G, Shrestha A, TE Raa, Tonino SH, van der Spek E, van Gelder M, van Kampen R, Wasik-Szczepanek E, Wróbel T, Yuñez-San Segundo L, Yassin M, Pocali B, Vandenberghe E, Iyengar S, Varettoni M, Vitale C, Coscia M, Rambaldi A, Montserrat E, Cuneo A, Stavroyianni N, Trentin L, Stamatopoulos K^*, Ghia P^*. The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL. Am J Hematol 2024; 98(12): 1856-1868.
• Hernández-Sánchez A^*, Villaverde-Ramiro Á, Arellano-Rodrigo E, Garrote M, Martin I, Mosquera-Orgueira A, Gómez-Casares MT, Ferrer-Marín F, Such E, Velez P, Ayala R, Angona A, De Las Heras N, Magro E, Mata-Vazquez MI, Fox ML, De Villambrosía S, Ramirez MJ, García A, García-Gutiérrez V, Cáceres A, Durán MA, Senín A, Raya JM, González JM, Cuevas B, Xicoy B, Pérez-Encinas M, Bellosillo B, Álvarez-Larrán A, Hernández-Rivas JM^*, Hernández-Boluda JC^*, Spanish MPN Group (GEMFIN). The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. Am J Hematol 2024; 99: 755-758.
• Diez-Feijoo R, Andrade-Campos M, Gibert J, Sánchez-González B, Fernández-Ibarrondo L, Fernández-Rodríguez MC, Garcia N, Camacho L, Lafuente M, Vazquez I, Colomo L, Salar A^*, Bellosillo B. Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas. Cancers 2024; 16(2): 321.